These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 24247137)
1. Antiapicoplast and gametocytocidal screening to identify the mechanisms of action of compounds within the malaria box. Bowman JD; Merino EF; Brooks CF; Striepen B; Carlier PR; Cassera MB Antimicrob Agents Chemother; 2014; 58(2):811-9. PubMed ID: 24247137 [TBL] [Abstract][Full Text] [Related]
2. Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target Pathways. Allman EL; Painter HJ; Samra J; Carrasquilla M; Llinás M Antimicrob Agents Chemother; 2016 Nov; 60(11):6635-6649. PubMed ID: 27572391 [TBL] [Abstract][Full Text] [Related]
3. Identification of MMV malaria box inhibitors of plasmodium falciparum early-stage gametocytes using a luciferase-based high-throughput assay. Lucantoni L; Duffy S; Adjalley SH; Fidock DA; Avery VM Antimicrob Agents Chemother; 2013 Dec; 57(12):6050-62. PubMed ID: 24060871 [TBL] [Abstract][Full Text] [Related]
4. Isoprenoid precursor biosynthesis is the essential metabolic role of the apicoplast during gametocytogenesis in Plasmodium falciparum. Wiley JD; Merino EF; Krai PM; McLean KJ; Tripathi AK; Vega-Rodríguez J; Jacobs-Lorena M; Klemba M; Cassera MB Eukaryot Cell; 2015 Feb; 14(2):128-39. PubMed ID: 25446055 [TBL] [Abstract][Full Text] [Related]
5. A chemical rescue screen identifies a Plasmodium falciparum apicoplast inhibitor targeting MEP isoprenoid precursor biosynthesis. Wu W; Herrera Z; Ebert D; Baska K; Cho SH; DeRisi JL; Yeh E Antimicrob Agents Chemother; 2015 Jan; 59(1):356-64. PubMed ID: 25367906 [TBL] [Abstract][Full Text] [Related]
6. Luciferase-Based, High-Throughput Assay for Screening and Profiling Transmission-Blocking Compounds against Plasmodium falciparum Gametocytes. Lucantoni L; Fidock DA; Avery VM Antimicrob Agents Chemother; 2016 Apr; 60(4):2097-107. PubMed ID: 26787698 [TBL] [Abstract][Full Text] [Related]
7. Chemical rescue of malaria parasites lacking an apicoplast defines organelle function in blood-stage Plasmodium falciparum. Yeh E; DeRisi JL PLoS Biol; 2011 Aug; 9(8):e1001138. PubMed ID: 21912516 [TBL] [Abstract][Full Text] [Related]
8. Small molecule inhibition of apicomplexan FtsH1 disrupts plastid biogenesis in human pathogens. Amberg-Johnson K; Hari SB; Ganesan SM; Lorenzi HA; Sauer RT; Niles JC; Yeh E Elife; 2017 Aug; 6():. PubMed ID: 28826494 [TBL] [Abstract][Full Text] [Related]
9. Probing the Open Global Health Chemical Diversity Library for Multistage-Active Starting Points for Next-Generation Antimalarials. Abraham M; Gagaring K; Martino ML; Vanaerschot M; Plouffe DM; Calla J; Godinez-Macias KP; Du AY; Wree M; Antonova-Koch Y; Eribez K; Luth MR; Ottilie S; Fidock DA; McNamara CW; Winzeler EA ACS Infect Dis; 2020 Apr; 6(4):613-628. PubMed ID: 32078764 [TBL] [Abstract][Full Text] [Related]
11. 4-Nitro styrylquinoline is an antimalarial inhibiting multiple stages of Plasmodium falciparum asexual life cycle. Roberts BF; Zheng Y; Cleaveleand J; Lee S; Lee E; Ayong L; Yuan Y; Chakrabarti D Int J Parasitol Drugs Drug Resist; 2017 Apr; 7(1):120-129. PubMed ID: 28285258 [TBL] [Abstract][Full Text] [Related]
12. Validation of Putative Apicoplast-Targeting Drugs Using a Chemical Supplementation Assay in Cultured Human Malaria Parasites. Uddin T; McFadden GI; Goodman CD Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109165 [TBL] [Abstract][Full Text] [Related]
13. High-Content Screening of the Medicines for Malaria Venture Pathogen Box for Plasmodium falciparum Digestive Vacuole-Disrupting Molecules Reveals Valuable Starting Points for Drug Discovery. Tong JX; Chandramohanadas R; Tan KS Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311064 [No Abstract] [Full Text] [Related]
14. Apicoplast Metabolism: Parasite's Achilles' Heel. Kadian K; Gupta Y; Singh HV; Kempaiah P; Rawat M Curr Top Med Chem; 2018; 18(22):1987-1997. PubMed ID: 30499407 [TBL] [Abstract][Full Text] [Related]
15. Imaging flow cytometry for the screening of compounds that disrupt the Plasmodium falciparum digestive vacuole. Chia WN; Lee YQ; Tan KS Methods; 2017 Jan; 112():211-220. PubMed ID: 27389304 [TBL] [Abstract][Full Text] [Related]
16. Determination of the active stereoisomer of the MEP pathway-targeting antimalarial agent MMV008138, and initial structure-activity studies. Yao ZK; Krai PM; Merino EF; Simpson ME; Slebodnick C; Cassera MB; Carlier PR Bioorg Med Chem Lett; 2015 Apr; 25(7):1515-9. PubMed ID: 25754494 [TBL] [Abstract][Full Text] [Related]
17. Progressing the global antimalarial portfolio: finding drugs which target multiple Plasmodium life stages. Smith PW; Diagana TT; Yeung BK Parasitology; 2014 Jan; 141(1):66-76. PubMed ID: 23746048 [TBL] [Abstract][Full Text] [Related]
18. Delayed death in the malaria parasite Plasmodium falciparum is caused by disruption of prenylation-dependent intracellular trafficking. Kennedy K; Cobbold SA; Hanssen E; Birnbaum J; Spillman NJ; McHugh E; Brown H; Tilley L; Spielmann T; McConville MJ; Ralph SA PLoS Biol; 2019 Jul; 17(7):e3000376. PubMed ID: 31318858 [TBL] [Abstract][Full Text] [Related]
19. A mevalonate bypass system facilitates elucidation of plastid biology in malaria parasites. Swift RP; Rajaram K; Liu HB; Dziedzic A; Jedlicka AE; Roberts AD; Matthews KA; Jhun H; Bumpus NN; Tewari SG; Wallqvist A; Prigge ST PLoS Pathog; 2020 Feb; 16(2):e1008316. PubMed ID: 32059044 [TBL] [Abstract][Full Text] [Related]
20. The multifunctional autophagy pathway in the human malaria parasite, Plasmodium falciparum. Cervantes S; Bunnik EM; Saraf A; Conner CM; Escalante A; Sardiu ME; Ponts N; Prudhomme J; Florens L; Le Roch KG Autophagy; 2014 Jan; 10(1):80-92. PubMed ID: 24275162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]